Thomas Baer

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

Xiao-Jun Ma, Zuncai Wang, Paula D. Ryan et al. · Cancer Cell · 2004 · 962 citations · Full text

Medicine, Genetics, Oncology +16

Gene expression profiles of human breast cancer progression

Xiaojun Ma, Ranelle Salunga, J. Todd Tuggle et al. · Proceedings of the National Academy of Sciences · 2003 · 898 citations

Life Sciences, Molecular Biology, Oncology +17

Novel Chimeric Histone Deacetylase Inhibitors: A Series of Lapatinib Hybrides as Potent Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), and Histone Deacetylase Activity

Siavosh Mahboobi, Andreas Sellmer, Mathias Winkler et al. · Journal of Medicinal Chemistry · 2010 · 97 citations · Full text

Medicine, Oncology, Pharmacology +17

Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases

Siavosh Mahboobi, Stefan Dove, Andreas Sellmer et al. · Journal of Medicinal Chemistry · 2009 · 92 citations · Full text

Medicine, Oncology, Pharmacology +14

Therapist–Patient Alliance, Patient–Therapist Alliance, Mutual Therapeutic Alliance, Therapist–Patient Concordance, and Outcome of CBT in GAD

Christin Langhoff, Thomas Baer, Doris Zubraegel et al. · Journal of Cognitive Psychotherapy · 2008 · 51 citations

Education, Counseling, Psychology +16